z-logo
open-access-imgOpen Access
[Corrigendum] In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT‑116 xenograft model in nude mice
Author(s) -
Sitelbanat Yassin,
Jialiang Hu,
Hanmei Xu,
Ce Li,
Sarra Setrerrahmane
Publication year - 2020
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2020.7503
Subject(s) - in vivo , sunitinib , in vitro , cancer , oncogene , medicine , cancer research , oncology , medical physics , computer science , nuclear medicine , cell cycle , biology , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom